The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026
Post-discharge healthcare resource utilization and surfactant administration in moderate to late preterm infants with respiratory distress syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sun Xuezheng, Mowla Sanjida, Simpson Annie N, Lahiri Aditi, Edelman Dana, Liu-Yi Sue, Corman Shelby, Fuentes Daniel, Dukhovny Dmitry, Kuzniewicz Michael W
Аннотация
OBJECTIVES: Respiratory distress syndrome (RDS) is common in preterm infants, accounting for significant healthcare resource utilization (HCRU). To address knowledge gaps in mature preterm infants, this study evaluated one-year post-discharge HCRU by surfactant administration.
METHODS: This study included moderate (32 0/7-33 6/7 weeks) and late preterm infants (34 0/7-36 6/7 weeks) with RDS (ICD-10-CM P22.0) requiring >12 h of respiratory support during birth hospitalization at a Kaiser Permanente Hospital in Northern California (2019-2023). Nested logistic regression estimated adjusted odds ratios (aORs) for associations between surfactant receipt and one-year outcomes [any/respiratory emergency department (ED) visits and hospitalizations] across four sequential models: unadjusted; +birth/demographic factors; +clinical severity; +social factors.
RESULTS: Among 1,674 infants, 316 (18.9%) received surfactant and had greater in-hospital severity (moderate-to-severe RDS 23.1% vs. 2.3%; invasive ventilation 25.6% vs. 1.3%; respiratory support ≥94 h 54.2% vs 26.1%; p < 0.001). After discharge, surfactant treated infants were more likely to have any ED visits and hospitalizations compared to non-treated infants. However, associations were attenuated and no longer significant after adjustment for birth/demographics, clinical severity and social factors for any ED visits (aOR:1.28 [0.93, 1.76]) and hospitalizations (aOR:1.33 [0.74, 2.40]). Respiratory ED visits remained elevated after adjustment while estimates for respiratory hospitalizations were imprecise.
CONCLUSION: Among moderate and late preterm infants with RDS, surfactant receipt was associated with greater in-hospital severity. However, adjusting for severity when estimating odds of post-discharge outcomes resulted in small, inconsistent differences. Future studies should consider more precise measures of RDS severity and the impact of post-discharge factors on HCRU.
METHODS: This study included moderate (32 0/7-33 6/7 weeks) and late preterm infants (34 0/7-36 6/7 weeks) with RDS (ICD-10-CM P22.0) requiring >12 h of respiratory support during birth hospitalization at a Kaiser Permanente Hospital in Northern California (2019-2023). Nested logistic regression estimated adjusted odds ratios (aORs) for associations between surfactant receipt and one-year outcomes [any/respiratory emergency department (ED) visits and hospitalizations] across four sequential models: unadjusted; +birth/demographic factors; +clinical severity; +social factors.
RESULTS: Among 1,674 infants, 316 (18.9%) received surfactant and had greater in-hospital severity (moderate-to-severe RDS 23.1% vs. 2.3%; invasive ventilation 25.6% vs. 1.3%; respiratory support ≥94 h 54.2% vs 26.1%; p < 0.001). After discharge, surfactant treated infants were more likely to have any ED visits and hospitalizations compared to non-treated infants. However, associations were attenuated and no longer significant after adjustment for birth/demographics, clinical severity and social factors for any ED visits (aOR:1.28 [0.93, 1.76]) and hospitalizations (aOR:1.33 [0.74, 2.40]). Respiratory ED visits remained elevated after adjustment while estimates for respiratory hospitalizations were imprecise.
CONCLUSION: Among moderate and late preterm infants with RDS, surfactant receipt was associated with greater in-hospital severity. However, adjusting for severity when estimating odds of post-discharge outcomes resulted in small, inconsistent differences. Future studies should consider more precise measures of RDS severity and the impact of post-discharge factors on HCRU.